Caseware UK (AP4) 2023.0.135 2023.0.135 2024-05-312024-05-31false2023-06-01No description of principal activityfalse22trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 09581636 2023-06-01 2024-05-31 09581636 2022-06-01 2023-05-31 09581636 2024-05-31 09581636 2023-05-31 09581636 c:Director1 2023-06-01 2024-05-31 09581636 c:Director2 2023-06-01 2024-05-31 09581636 d:CurrentFinancialInstruments 2024-05-31 09581636 d:CurrentFinancialInstruments 2023-05-31 09581636 d:CurrentFinancialInstruments d:WithinOneYear 2024-05-31 09581636 d:CurrentFinancialInstruments d:WithinOneYear 2023-05-31 09581636 d:ShareCapital 2024-05-31 09581636 d:ShareCapital 2023-05-31 09581636 d:RetainedEarningsAccumulatedLosses 2024-05-31 09581636 d:RetainedEarningsAccumulatedLosses 2023-05-31 09581636 c:FRS102 2023-06-01 2024-05-31 09581636 c:AuditExempt-NoAccountantsReport 2023-06-01 2024-05-31 09581636 c:FullAccounts 2023-06-01 2024-05-31 09581636 c:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 09581636 2 2023-06-01 2024-05-31 09581636 e:PoundSterling 2023-06-01 2024-05-31 iso4217:GBP xbrli:pure

Registered number: 09581636









HSP MEDICAL LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MAY 2024

 
HSP MEDICAL LIMITED
REGISTERED NUMBER: 09581636

STATEMENT OF FINANCIAL POSITION
AS AT 31 MAY 2024

2024
2023
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
-
3,009

Cash at bank and in hand
 5 
13,120
18,279

  
13,120
21,288

Creditors: amounts falling due within one year
 6 
(12,897)
(19,459)

Net current assets
  
 
 
223
 
 
1,829

Total assets less current liabilities
  
223
1,829

  

Net assets
  
223
1,829


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
123
1,729

  
223
1,829


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




___________________________
Dr Harminder Panesar
___________________________
Sharmila Panesar
Director
Director


Page 1

 
HSP MEDICAL LIMITED
REGISTERED NUMBER: 09581636
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 MAY 2024

Date: 3 September 2024
Date:3 September 2024

The notes on pages 3 to 5 form part of these financial statements.

Page 2

 
HSP MEDICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2024

1.


General information

The company is a private company  limited by shares, registered in  England and Wales. The address of the registered office is The Old Wheel House, 31-37 Church Street, Reigate , Surrey, RH2 0AD.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Page 3

 
HSP MEDICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2024

2.Accounting policies (continued)

 
2.5

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.6

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.7

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.8

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

2024
2023
£
£

Wages and salaries
6,719
6,720

6,719
6,720


The average monthly number of employees, including directors, during the year was 2 (2023 - 2).


4.


Debtors

2024
2023
£
£


Trade debtors
-
3,009

-
3,009


Page 4

 
HSP MEDICAL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2024

5.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
13,120
18,279

13,120
18,279



6.


Creditors: Amounts falling due within one year

2024
2023
£
£

Corporation tax
3,866
4,860

Other creditors
6,987
12,690

Accruals and deferred income
2,044
1,909

12,897
19,459



7.
Director's advances, credits and guarantees


2024

Balance brought forward
Advances/(credits) to the directors
Amounts repaid
Balance outstanding

£
£
£
£

Dr Harminder Panesar
(8,574)
14,443
(10,192)
(4,324)

Sharmila Panesar
(4,116)
10,203
(8,750)
(2,663)

2023

Balance brought forward
Advances/(credits) to the directors
Amounts repaid
Balance outstanding

£
£
£
£

Dr Harminder Panesar
(7,244)
11,371
(12,701)
(8,574)

Sharmila Panesar
(2,411)
9,052
(10,756)
(4,116)

 
Page 5